BIZENGRI J Code: J9382

Drug & Product Overview

HCPCS Descriptor Injection, zenocutuzumab-zbco, 1 mg

HCPCS Added Date July 1, 2025

Manufacturer Partner Therapeutics, Inc

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Form Injection

About BIZENGRI

Bizengri is a medication aligned to the HCPCS J Code: J9382 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravenous route and manufactured by Partner Therapeutics, Inc.

According to CMS Drug Use Information: This medication is used to treat certain types of cancer (such as lung, pancreas, bile duct cancer). Zenocutuzumab belongs to a class of drugs known as monoclonal antibodies. Zenocutuzumab works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 1 of 2 NDCs — log in for the full crosswalk.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
71837-1000-02	Bizengri	Partner Therapeutics, Inc.	750	375 MG / 18.75 ML
•••••-••••-•• Log in to view	BIZENGRI

Login to view 1 more NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

BIZENGRI Pricing & Reimbursement

J9382 Private Payer Reimbursement

$34.38 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

BIZENGRI Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 25%

Avg. Days to File 4.8days

Avg. Days to Pay 23.5days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9382 claims analytics on FocalPoint →

BIZENGRI CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

BIZENGRI Medically Unlikely Edits (MUE)

The most billing units of J9382 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient

750 units / day

= 750 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

BIZENGRI Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Advanced unresectable or metastatic NRG1 fusion-positive cholangiocarcinoma Advanced unresectable or metastatic NRG1 fusion-positive non-small cell lung cancer Advanced unresectable or metastatic NRG1 fusion-positive pancreatic adenocarcinoma

Frequently Asked Questions

Is there an available BIZENGRI billing and coding guide?

Billing and coding information for BIZENGRI can be found through Partner Therapeutics, Inc. Visit Here →

Are there any available BIZENGRI patient assistance programs?

BIZENGRI patient assistance information can be found through Partner Therapeutics, Inc. Visit Here →

Where can I find BIZENGRI prescribing information?

BIZENGRI prescribing information can be found at the link below. Visit Here →

Where can I find BIZENGRI side effect information?

Side effect information for BIZENGRI can be found through MedlinePlus. Visit Here →

Does billing BIZENGRI require JZ/JW wastage modifiers?

CMS does not include BIZENGRI (J9382) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9382. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.